Poly(ADP-ribose) polymerases covalently modify strand break termini in DNA fragments in vitro by Talhaoui, Ibtissam et al.
Published online 28 July 2016 Nucleic Acids Research, 2016, Vol. 44, No. 19 9279–9295
doi: 10.1093/nar/gkw675
Poly(ADP-ribose) polymerases covalently modify
strand break termini in DNA fragments in vitro
Ibtissam Talhaoui1,2,†, Natalia A. Lebedeva3,†, Gabriella Zarkovic1,2,†, Christine Saint-Pierre4,
Mikhail M. Kutuzov3, Maria V. Sukhanova3, Bakhyt T. Matkarimov5, Didier Gasparutto4,
Murat K. Saparbaev1,2, Olga I. Lavrik3,6,* and Alexander A. Ishchenko1,2,*
1Laboratoire Stabilite´ Ge´ne´tique et Oncogene`se CNRS, UMR 8200, Univ. Paris-Sud, Universite´ Paris-Saclay,
F-94805 Villejuif, France, 2Gustave Roussy, Universite´ Paris-Saclay, F-94805 Villejuif, France, 3SB RAS Institute of
Chemical Biology and Fundamental Medicine, Lavrentiev Av. 8, Novosibirsk 630090, Russia, 4Universite´ Grenoble
Alpes, CEA, INAC/SPrAM UMR5819 CEA CNRS UGA, F-38000 Grenoble, France, 5National Laboratory Astana,
Nazarbayev University, Astana 010000, Kazakhstan and 6Department of Natural Sciences, Novosibirsk State
University, 2 Pirogova St., Novosibirsk 630090, Russia
Received September 23, 2014; Revised June 28, 2016; Accepted July 14, 2016
ABSTRACT
Poly(ADP-ribose) polymerases (PARPs/ARTDs) use
nicotinamide adenine dinucleotide (NAD+) to catal-
yse the synthesis of a long branched poly(ADP-
ribose) polymer (PAR) attached to the acceptor
amino acid residues of nuclear proteins. PARPs
act on single- and double-stranded DNA breaks
by recruiting DNA repair factors. Here, in in vitro
biochemical experiments, we found that the mam-
malian PARP1 and PARP2 proteins can directly
ADP-ribosylate the termini of DNA oligonucleotides.
PARP1 preferentially catalysed covalent attachment
of ADP-ribose units to the ends of recessed
DNA duplexes containing 3′-cordycepin, 5′- and 3′-
phosphate and also to 5′-phosphate of a single-
stranded oligonucleotide. PARP2 preferentially ADP-
ribosylated the nicked/gapped DNA duplexes con-
taining 5′-phosphate at the double-stranded termini.
PAR glycohydrolase (PARG) restored native DNA
structure by hydrolysing PAR-DNA adducts gener-
ated by PARP1 and PARP2. Biochemical and mass
spectrometry analyses of the adducts suggested
that PARPs utilise DNA termini as an alternative
to 2′-hydroxyl of ADP-ribose and protein accep-
tor residues to catalyse PAR chain initiation either
via the 2′,1′′-O-glycosidic ribose-ribose bond or via
phosphodiester bond formation between C1′ of ADP-
ribose and the phosphate of a terminal deoxyribonu-
cleotide. This new type of post-replicative modifica-
tion of DNA provides novel insights into the molecu-
lar mechanisms underlying biological phenomena of
ADP-ribosylation mediated by PARPs.
INTRODUCTION
Cellular DNA is constantly damaged by exogenous and en-
dogenous factors resulting in base and sugar alterations and
DNA strand breaks (1). Single- and double-strand DNA
breaks (SSBs and DSBs, respectively) can be generated ei-
ther directly by oxygen free radicals or as intermediates of
DNA excision repair (2). Failure to detect and repair DNA
strand breaks can have deleterious consequences for the
cell, e.g. chromosomal aberrations, genomic instability and
cell death. The poly(ADP-ribose) polymerase (PARP) fam-
ily of proteins, also referred as diphtheria toxin-like ADP-
ribosyltransferases (ARTD) according to the new nomen-
clature, includes 18 known members identified by homol-
ogy searching. They catalyse the synthesis of polymers of
ADP-ribose (PAR) covalently attached to acceptor proteins
using nicotinamide adenine dinucleotide (NAD+) as a sub-
strate (3–5). PARP1 and PARP2 proteins are considered
DNA damage sensors that after binding to strand breaks,
poly(ADP-ribosyl)ate themselves and nuclear acceptor pro-
teins that regulate the function of the modified proteins.
Particularly, PARP1-catalysed self-poly-ADP-ribosylation
(PARylation) andmodification of nuclear proteins is greatly
activated after exposure of cells to DNA-damaging agents
(6). The covalently attached ADP-ribose polymer with a
complex branched structure confers negative charge to
PARPs and histones, resulting in the decrease inDNAbind-
ing and electrostatic repulsion of these proteins from DNA
(7,8). It was postulated that at lower levels of cellular DNA
damage, PARPs regulate the DNA repair pathways by re-
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cruiting proteins to strand breaks, and at more severe DNA
damage, promote cell death via necrosis, apoptosis or both
(3,9). The widespread presence of PARP proteins in eukary-
otes and their unusual post-translational modification ac-
tivity could be explained by the fact that in eukaryotic cells,
DNA is tightly packed into a complex referred to as chro-
matin, a highly complicated structure with several levels of
organization (10). Chromatin structure imposes restrictions
upon DNA–protein interactions, and several studies have
shown that chromatin packaging restricts the ability of the
DNA repair machinery to access the sites of DNA dam-
age (11,12). It is widely accepted that the PARP-catalysed
PARylation of nuclear proteins is required for regulation of
DNA repair and transcription in the context of chromatin
in eukaryotic cell nuclei (13,14).
Mammalian PARP1 accounts for 80–90% of measur-
able poly(ADP-ribose) synthesis after DNA damage (15).
PARP1 is a multi-domain protein composed of six dis-
tinctmodules including twoN-terminal zinc finger domains
(Zn1 and Zn2) responsible for initial binding to altered
DNA structures; the third zinc-binding domain (Zn3) and
tryptophan-glycine-arginine (WGR) domain participating
inDNAbinding and formation of a network of interdomain
contacts critical for activation of the C-terminal catalytic
(CAT) domain resulting in NAD+ cleavage and formation
of PAR polymer; and a central auto-modification domain
containing a cluster of glutamic acid residues serving as
ADP-ribose acceptor sites: a BRCA1 C-terminal (BRCT)
motif (16–18). Both PARP1 and PARP2 have WGR and
CAT domains and the overall three-dimensional structures
of theirs CAT domains are similar (19). As compared to
PARP1, PARP2 does not contain the N-terminal zinc fin-
ger and BRCT domains, which are replaced by a smaller N-
terminal region of unknown function, which is not strictly
required for DNA-dependent activation (20). PARP2 is
preferentially activated by a SSB harbouring a 5′ phosphate
and recognises and is differently activated by a diverse set of
damaged DNA structures as compared to PARP1, suggest-
ing that the two enzymes have non-overlapping functions in
DNA repair (20–22).
Endogenous non-bulky DNA base damage is removed
via two overlapping pathways: DNA glycosylase-initiated
base excision repair (BER) and apurinic/apyrimidinic (AP)
endonuclease-mediated nucleotide incision repair (NIR)
(23). In BER, a DNA glycosylase excises the modified base,
leaving either an AP site or a SSB with 3′-phosphoaldehyde
and/or 3′-phosphate groups; all these genotoxic intermedi-
ates are then hydrolysed by an AP endonuclease (APE1 in
human cells) prior to the gap-filling synthesis step (24,25).
It should be noted that AP sites and 3′-phosphate termini
can also be removed in the AP endonuclease-independent
manner by tyrosyl-DNA phosphodiesterase 1 (Tdp1) and
polynucleotide kinase (PNK), respectively (26,27). In NIR,
a damage-specific AP endonuclease makes an incision 5′ to
a damaged base, in a DNA glycosylase-independent man-
ner, producing a SSB with a 3′-hydroxyl (3′OH) terminus
and a 5′ dangling damaged nucleotide (28). Thus, DNA
strand breaks generated either directly or as intermediates
of DNA excision repair contain 3′ or 5′ blocking groups or
both and therefore require additional cleansing steps before
DNA repair synthesis and ligation. It was suggested that
the PARylation of acceptor proteins promotes repair of a
SSB via recruitment and retention of the XRCC1 protein;
the latter process in turn depends on the chromatin context
(29). XRCC1 is a key scaffold protein in the BER and NIR
pathways and binds to a SSB and then recruits and activates
(through protein–protein interactions) DNA repair factors
necessary for end cleansing, DNA synthesis and ligation
(30). Mice deficient in PARPs have a phenotype hypersen-
sitive to ionizing radiation and to DNA alkylating agents
(33–35). Furthermore, PARP-deficient cells are hypersen-
sitive to topoisomerase I (Top1) inhibitors such as camp-
tothecins; this phenomenon is suggestive of the involvement
of PARPs in the repair of Top1-DNA cleavage complexes
(31).
In addition to their role in SSB repair, DNA damage-
activated PARPs perform an important function in the re-
pair of DSBs and influence the relative contribution of ho-
mologous recombination (HR), canonical and alternative
nonhomologous end-joining (C-NHEJ andA-NHEJ) path-
ways (32). PARP1 is recognised as a key component of A-
NHEJ, acting at the initiation step of DSB repair in cooper-
ation with the DSB sensors MRE11 and NBS1 (33). It was
shown that both PARP1 and PARP2 are recruited to sites of
DNA damage induced by laser microirradiation and are re-
quired for hydroxyurea-induced HR to ensure cell survival
after replication arrest (34,35). Taken together, these obser-
vations are indicative of the critical role of PARPs in the
repair of both SSBs and DSBs.
Moreover, the PARP-catalysed covalent PARylation of
proteins is a reversible process because PAR is degraded
by several ADP-ribosylhydrolases including poly(ADP-
ribose) glycohydrolase (PARG) (36), ADP ribosyl-acceptor
hydrolase 3 (ARH3) (37) and terminal ADP-ribose pro-
tein glycohydrolase 1 (TARG1) (38). PARG is a major PAR
glycohydrolase in mammalian cells that removes most of
the PAR polymer but leaves a single ADP-ribose attached
to the protein; this residue is then eliminated by TARG1.
Disruption of the PARG gene in mice results in embryonic
mortality (39) and PARG-deficient cells show increased cell
death and impaired repair of DNA base damage and strand
breaks (40–42), indicating that accumulation of the PARy-
lated macromolecules is highly toxic to the cell.
The phenomenon of NAD+-dependent PARylation was dis-
covered more than 50 years ago, but it is still unclear how
this post-translational modification governs a multitude of
cellular processes including DNA repair, transcription, chro-
matin dynamics and cell death (43). Here, we studied the
interactions of PARP enzymes with DNA damage and re-
pair intermediates using in vitro approaches. Our results re-
veal that both mammalian PARP1 and PARP2 can cova-
lently modify DNA oligonucleotide duplexes by addition
of multiple poly(ADP-ribose) units to 3′ and 5′ extremi-
ties of DNA. Therefore, along with this newly uncovered
post-replicative modification, DNA can be regarded as a
substrate for the PARP1- and PARP2-catalysed reaction of
poly-ADP-ribosylation. The PARP-catalysed DNA PARy-
lation is reversible because PARG efficiently removes the
PAR polymer from DNA and restores initial DNA struc-
ture. The characteristics and possible functional role of the
new activity of PARPs are discussed.
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MATERIALS AND METHODS
Chemicals, reagents and proteins
Proteinase K from Tritirachium album and Deoxyribonu-
clease I from bovine pancreas (DNAse I) were purchased
from Sigma–Aldrich (France), CIP (alkaline phosphatase,
calf intestinal) and E. coli exonuclease I (ExoI) were pur-
chased from New England Biolabs France (Evry, France).
SVPDE1 (snake venomphosphodiesterase 1) fromCrotalus
adamanteus was from Worthington (Biochemical Corpo-
ration). Human tyrosyl-DNA phosphodiesterase 1 (Tdp1)
was purified as described previously (44). The purified hu-
man Nudix (nucleoside diphosphate-linked moiety X)-type
motif 16 (NUDT16) protein was kindly provided by Dr
Ivan Ahel (University of Oxford, U.K.).
Human poly(ADP-ribose) polymerase 1 (PARP1; EC
2.4.2.30) and bovine PARG were purchased from Trevi-
gen (Gaithersburg, USA). The plasmid coding for murine
PARP2 was kindly provided by Dr V. Schreiber (ESBS,
Illkirch, France). The untagged PARP2 protein was ex-
pressed and purified from insect cells as described previ-
ously (22).
Oligonucleotides
Sequences of the oligonucleotides and their duplexes used
in the present work are shown in Figure 1. All oligonu-
cleotides were purchased from Eurogentec (Seraing, Bel-
gium) including regular oligonucleotides and those con-
taining -anomeric 2′-deoxyadenosine (dA), tetrahydro-
furan (THF), 5,6-dihydrouracil (DHU), 3′-phosphate, 3′-
thiophosphate and 3′-terminal riboadenosine. Prior to en-
zymatic assays, the oligonucleotides were labelled either at
the 5′ end using T4 polynucleotide kinase (New England
Biolabs, OZYME France) in the presence of [ -32P]ATP
(3000 Ci.mmol−1) (PerkinElmer) or at the 3′ end by means
of terminal deoxynucleotidyl transferase (New England Bi-
olabs) in the presence of [-32P]-3′-dATP (cordycepin 5′-
triphosphate, 5000 Ci.mmol−1; PerkinElmer) according to
the manufacturer’s protocol. After the reactions, radioac-
tively labelled oligonucleotides were desalted on a Sephadex
G-25 column equilibrated with water and then annealed
with a corresponding complementary strand for 3 min at
65◦C in the buffer consisting of 20 mM HEPES-KOH (pH
7.6) and 50 mMKCl. Radioactive labelling of duplex DNA
was also performed using radioactive [adenylate-32P]NAD+
(800 Ci.mmol−1) (PerkinElmer) in the presence of PARPs,
oligonucleotides and 1 mM cold NAD+. To generate DNA
duplex containing 3′-terminal 32P residue the 3′dAM32P-
labelled ExoA•RexT duplex was incubated with 100 nM
Tdp1 in 50 mM Tris-HCl pH 7.5, 25 mM KCl for 2 h at
25◦C.
The following oligonucleotides (5′→3′) were mostly used
to quantify PARylation of DNA ends by PARPs: 17-mer
d(AGCATTCGXGACTGGGT) where X is dA, dA or
THF; Exo20, d(GTGGCGCGGAGACTTAGAGA); Ex-
oDHU, d(GTGGCGCGGAGACTTAGAGA-DHU);
ExoA, d(GTGGCGCGGAGACTTAGAGAA);
ExoARib, d(GTGGCGCGGAGACTTAGAGA)-
riboA; ExoAp and ExoAThio-p, d(GTGGCGCG
GAGACTTAGAGAAp), where p is a 3′-terminal
phosphate and thiophosphate, respectively; 5P-Exo19,
d(pATTTGGCGCGGGGAATTCC) and 5P-Exo18,
d(pTTTGGCGCGGGGAATTCC), where 5P is a
5′-terminal phosphate; and complementary Rex-T,
d(GGAATTCCCCGCGCCAAATTTCTCTAAGTCTC
CGCGCCAC). The nicked, gapped or recessed DNA
duplexes Exo20•RexTnick/gap/rec and ExoA•RexTnick/gap/rec
consisted of RexT and Exo20 or ExoA, and 5P-Exo19 or
5P-Exo18, respectively (Figure 1).
Activity assay for poly(ADP-ribose) polymerase
The standard reaction mixture (10 l) for a DNA PARy-
lation assay contained 20 nM [32P]labelled oligonucleotide,
50 nM PARP1 or PARP2, 1 mM NAD+, 20 mM HEPES-
KOH, pH 7.6, 50 mMKCl, 5 mMMgCl2, 1 mM DTT and
100 g.ml−1 BSA; the mixture was incubated for 30 min at
37◦C, unless otherwise stated. After reaction, the samples
were incubated in the presence of 50 ng/l proteinaseK and
0.15% SDS for 30 min at 50◦C followed by incubation for 3
min at 95◦C. The samples were desalted on a Sephadex G-
25 column (Amersham Biosciences) equilibrated in 7.5 M
urea, and then the products were analysed by electrophore-
sis in denaturing 20% (w/v) polyacrylamide gels (PAGE, 7
MUrea, 0.5x TBE, 42◦C). A wet gel was wrapped in a plas-
tic drape, then exposed to a Storage Fuji FLA-3000 Phos-
phor Screen, which was then scanned using Typhoon FLA
9500 and digital images were obtained and quantified using
FUJI Image Gauge V3.12 software.
Hydrolysis of the PAR–DNA polymer by PARG and DNA
modifying enzymes
The PARG reaction was performed after denaturing of
PARP proteins by heating a sample for 20 min at 80◦C;
then 50 pg/l PARG was added to reaction mixtures, and
samples were incubated for 30 min at 37◦C. Reaction prod-
ucts were analysed as described above. The CIP enzymatic
reaction was performed in CIP buffer (provided by New
England Biolabs) with 10 U of the enzyme. Reaction mix-
tures were incubated for 1 h at 37◦C. Hydrolysis of the
PAR–DNA polymer by SVPDE1 involved incubation of 20
nM DNA substrate with 50 nM PARP1 or PARP2, 1 mM
NAD+ in PARP buffer (see above) for 30 min at 37◦C, and
then 100 mU SVPDE1 was added to the reaction mixture,
and the latter was adjusted to 10 mM MgCl2 and 75 mM
Tris-HCl (pH 8.9) and incubated for 1 h at 37◦C followed
by incubation for 40 min at 37◦C with 10 U CIP in CIP
buffer, unless otherwise stated. The reaction products were
analysed as described above. Hydrolysis of the PAR–DNA
polymer by NUDT16 was performed using 2–20 M en-
zyme in DNA PARylation assay buffer supplemented with
10 mMMgCl2 for 18 h at 30◦C, unless otherwise stated.
Thin-layer chromatography (TLC)
Cellulose Thin Layer plates (Eastman chromatogram sheet)
were purchased from Eastman Kodak. The samples were
spotted on a TLC plate in 1 l aliquots, in a line 2 cm
away from the edge of the plate. The TLC plates were
developed using a solvent containing isobutyric acid/25%
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Figure 1. Schematic presentation of various DNA substrates used in this study.
NH4OH/H2O (50/1.5/28.9 by volume). After chromatog-
raphy, the TLC plates were dried and visualised using Fuji
FLA-3000 Phosphor Screen; the results were quantified in
the Image Gauge V3.12 software.
MALDI-TOF mass spectrometry analyses of the PARylated
DNA adducts
Mass spectrometry measurements were done as described
previously (45). Typically, 10 pmol of cold non-labelled
ExoA•RexTrec duplex (200 l) were incubated with 100
nM PARP1 or PARP2 in the presence of 1 mM NAD+
at 37◦C for 1 h. After, the reaction was stopped by heat-
ing the samples for 20 min at 80◦C and then 100 pg/l
PARG was added and samples were incubated further for
30 min at 37◦C. The reaction products were precipitated
with 2% lithium perchlorate in acetone, desalted and ei-
ther purified on denaturing PAGE or directly used for
the MALDI-TOF MS measurements. For the gel purifica-
tion, after electrophoresis the band corresponding tomono-
ADP-ribosylated 21-mer ExoA oligonucleotide was excised
and the DNA fragment was eluted in water at room temper-
ature for 4 h. Finally, mono-ADP-ribosylated DNA frag-
ments, isolated from 18 gel slices, were pooled and pre-
cipitated with 2% lithium perchlorate in acetone, desalted,
mixed with 5′-phosphorylated ExoA•RexTrec duplex con-
trol and then analysed byMALDI-TOFMS.MALDI-TOF
mass spectra were obtained in the negative mode on a Mi-
croflex mass spectrometer (Bruker, Wissembourg, France),
equipped with a 337 nm nitrogen laser and pulsed delay
source extraction. The matrix was prepared by dissolving
3-hydroxypicolinic acid in 10 mM ammonium citrate buffer
and a small amount of Dowex-50W 50 × 8-200 cation ex-
change resin (Sigma). The matrix (1 l) was added to the
sample (1 l) on the target plate and allowed to dry. The
spectra were calibrated using reference oligonucleotides of
known masses.
RESULTS
Human PARP1 and mouse PARP2 convert DNA oligonu-
cleotide duplexes into high-molecular-weight products in the
presence of NAD+
In our early studies, when characterising BER and NIR
pathways, we examined the effects of the purified hu-
man PARP1 protein on AP endonuclease 1 (APE1), act-
ing upon 5′-[32P]labelled 17-mer oligonucleotide duplexes
containing an AP site or an -anomeric nucleotide. Af-
ter analysis of the reaction products by denaturing poly-
acrylamide gel electrophoresis (PAGE), we observed forma-
tion of high-molecular-weight (HMW) DNA products in
the presence of PARP1 and NAD+ (Supplementary Fig-
ure S1 and Table S1). These HMW products were re-
sistant to proteinase K, SDS and heat treatment (Sup-
plementary Table S1 and Figure S2). To elucidate the
structure of these DNA complexes/adducts, we explored
biochemical activities of the purified human PARP1 and
mouse PARP2 proteins towards DNA substrates mimick-
ing various DNA repair intermediates. For this purpose,
we constructed the following DNA substrates: Exo20 (or
ExoA)•RexTnick and Exo20 (or ExoA)•RexTgap, which are
40-mer oligonucleotide duplexes containing a nick and one-
nucleotide gap, respectively, composed of a 40-mer (RexT)
template strand and two 20-mer (Exo20) or 21-mer (ExoA)
strands and phosphorylated 19-mer (5′pExo19) or 18-mer
(5′pExo18) complementary strands (Figure 1). In addition,
we preparedExo20•RexTrec, which is a recessed duplexwith
a 5′ single-stranded tail, composed of RexT and Exo20
(or ExoA). In each duplex, Exo20, ExoA or RexT were
[32P]labelled either at the 3′ end with 3′dAM32P (cordy-
cepin 5′-[32P]monophosphate) or at the 5′ end with 32P. The
3′-32P-cordycepin- and 5′-[32P]labelled oligonucleotide du-
plexes were incubated with the PARP proteins in the pres-
ence of NAD+; the reactions were stopped by adding 0.15%
SDS and proteinase K, and the products were analysed by
electrophoresis in a denaturing polyacrylamide gel.
Ten to forty percent of the [32P]labelled 21-mer oligonu-
cleotides were converted by PARPs to HMW DNA prod-
ucts, which were unable to enter the gel (Figure 2A and
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Figure 2. PARP-catalysed formation of high-molecular-weight (HMW) DNA products from oligonucleotide duplexes. (A) Denaturing PAGE analysis of
PARP1-generated HMW products (incubation with 3′-32P-cordycepin-labelled 40-mer nicked, gapped or recessed DNA). (B) Denaturing PAGE analysis
of PARP2-generated HMWproducts (incubation with 5′-[32P]labelled 40-mer nicked, gapped or recessed DNA). (C) Graphic representation of the average
numerical data on the formation of the HMW products by PARPs from gapped, nicked or recessed DNA duplexes. Each bar represents PARP activity
as mean ± SD from three independent experiments; (D) PARP1-catalysed PARylation in the presence of varying concentrations of NAD+. Fifty nM
PARP1 or 10 nM PARP2 was incubated with 20 nM DNA substrate and varying concentrations of NAD+ (5 nM to 1 mM) for 30 min at 37◦C. The
reaction products were analysed as described in Materials and Methods. Arrows indicate HMW and LMW PAR–DNA products and the 21-mer free
oligonucleotide.
B, lanes 2, 4 and 6), suggesting that DNA formed a com-
plex with the PAR polymer synthesised by PARPs. Some
of the smaller PAR–oligonucleotide products entered the
gel and migrated as smeared bands above free 21-mer frag-
ment (lanes 2, 4 and 6). The relative efficiency levels of the
PARP-catalysed formation of PAR–DNA products were
dependent on DNA duplex structures. PARP1 preferen-
tially reacted with the recessed duplex Exo20•RexTrec (34%
of HMW products formed) and to a much lesser extent
with gapped- and nicked-DNA duplexes (7–8% of HMW
products formed), whereas PARP2 preferred gapped and
nicked duplexes (30–32% of HMW products formed) as
compared to a recessed DNA (12%; Figure 2C). Then, we
examined NAD+ dependence and sensitivity of the HMW
PAR–DNA products to protease treatment. Accordingly,
we incubated 5′-[32P]labelled ExoA•RexTrec and PARP1
with varying concentrations of NAD+ and then treated the
samples with proteinase K in 0.15% SDS and analysed the
products of the reaction by denaturing PAGE. The PAR–
DNA products were not formed in the absence or at very
low concentrations ofNAD+ (0–50 nM; Figure 2D, lanes 1–
4), but their formation steadily increased at higher concen-
trations of NAD+ (10Mto 1mM; Figure 2D, lanes 6–10).
DNA-PARylation activity of PARP1 was stimulated in the
presence of Mg2+ with an optimum range from 2 to 5 mM
MgCl2 (Supplementary Figure S2B) similar to the MgCl2
requirements of the protein-PARylation activity described
previously (46,47). Proteinase K treatment and subsequent
heat treatment (5 min at 95◦C) in gel loading buffer did
not destroy the PAR–DNA products (Supplementary Fig-
ure S2). It is noteworthy that at the bottom of the gel, we ob-
served appearance of low-molecular-weight (LMW) PAR–
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DNA products migrating as a ladder of distinct fragments
above the 21-mer free oligonucleotide (Figure 2D, lanes 6–
10). This ladder strikingly resembled the DNA products
of primer-initiated DNA polymerase synthesis. Similar re-
sults were obtained with 5′-[32P]labelled ExoA•RexTrec and
PARP2 (Supplementary Figure S3). Taken together, these
results suggest that the HMWDNA products generated by
PARP enzymes in the presence of NAD+ are composed of
a long PAR polymer covalently attached to DNA and not
to the protein.
To rule out the possibility that the observed [32P]labelled
HMW DNA products are due to the presence of resid-
ual amounts of radioactive [adenylate-32P]NAD+ in non-
incorporated [ -32P]ATP, which was used for 5′-labelling
of the oligonucleotides, the following controls were pre-
pared. We incubated cold, unlabelled ExoA•RexTrec and
ExoA•RexTnick duplex oligonucleotides with PARP1 and
PARP2, respectively, in the presence of [ -32P]ATP and cold
1 mM NAD+. After reaction, the products were analysed
by denaturing PAGE. As expected, no [32P]labelled HMW
products were observed on the gel when we used unlabelled
DNA duplexes (Supplementary Figure S4). Moreover, the
observed formation of [32P]labelledHMWproducts with 5′-
[32P]labelled ExoA•RexTrec and ExoA•RexTnick substrates
was not dependent on the presence of [ -32P]ATP (Supple-
mentary Figure S4). This result indicated that under the
experimental conditions used there was no contamination
with radioactive [adenylate-32P]NAD+ or [ -32P]ATP in-
duced radioactive labelling of PAR polymers synthesised by
the oligonucleotide-activated PARPs.
Characterisation of the DNA substrate specificity of PARP-
catalysed PARylation
Next, we assessed in more detail the influence of the
type of DNA termini on PARP-catalysed formation of
PAR–DNA adducts with recessed duplexes and single-
stranded (ss) DNA (Figure 3). For this purpose, we in-
cubated [32P]labelled DNA oligonucleotides with varying
configurations and terminus structures in the presence of
PARPs and NAD+. After incubation, the products were
separated by denaturing PAGE and the relative amounts
of PAR–DNA adducts were measured. The results re-
vealed that (i) the presence of [32P]labelled cordycepin at
the 3′ end of recessed DNA (3′dAM32P-ExoA•RexTrec)
activated the PARP1-catalysed formation of HMW prod-
ucts, but abrogated the PARP2 activity; (ii) PARP2, but
not PARP1, was more active on the ExoA•RexTrec duplex
when ExoA was 5′-[32P] labelled; (iii) in contrast, PARP1,
but not PARP2, was active on the RexT•ExoArec duplex
when RexT was 5′-[32P] labelled; (iv) PARP1 was active
on the ss 3′- and 5′-[32P]labelled 40-mer RexT, but not
on ssExoA, whereas PARP2 was weakly active on both
types of ssDNA (Figure 3A). The presence of a ribonu-
cleotide at the 3′ end of 5′-[32P]labelled ExoARib in a re-
cessed duplex (5′ExoARib•RexTrec), as opposed to the reg-
ular (5′ExoA•RexTrec) duplex, stimulated PARP1 and did
not inhibit the PARP2 activity (Figure 3B, DNA substrates
N◦ 1 and 3). Overall, these results suggest that PARP1-
mediated DNA PARylation has a strong preference for a 2′-
hydroxyl group at the 3′ end of the 21-mer recessed strand,
which does not contain a 5′ phosphate (5′P) group, and
for 5′-phosphorylated intact (unnicked) 40-mer strand in ss
form or in the duplexes with a 5′-overhang. On the other
hand, PARP2 preferentially PARylates 5′-phosphorylated
recessed 21-mer strand with a 3′OH group at the 3′ end,
whereas the intact 40-mer strand (containing a phosphate
group in the 5′-overhang and 3′OH at the blunt end of the
duplex) is PARylated rather weakly (Figure 3B, DNA sub-
strates N◦1 and 3 versus N◦5 and 7). These results taken
together with the data presented in Figure 2, suggest that
PARP2 preferentially PARylates the 5′-phosphorylated re-
cessed 21-mer strand in the nicked or gappedDNAduplexes
with a 5′-phosphate residue located at the double-strand ter-
mini.
Next, we measured the total PARylation activity of
PARPs under the same conditions, but in the presence of ra-
dioactive [adenylate-32P]NAD+ and unlabelled cold DNA
substrates. It should be noted that under standard reaction
conditions in the presence of non-saturating DNA concen-
trations (20 nM), the overall level of PARP activity stim-
ulation was relatively low as compared to control without
DNA (up to 4- and 2-fold for PARP1 and PARP2, respec-
tively). In agreement with other reports (20,22,48), the du-
plexes with nicks were as good activators of overall PARP1-
catalysed PARylation as recessed duplexes, whereas ssDNA
was a poor activator (Supplementary Figure S5A). This is
in contrast to DNA substrate preference of the PARP1-
catalysed DNA-PARylation (Figures 2 and 3). In case of
PARP2, the maximal level of total PARylation activity was
reached when we used the 5′-phosphorylated nicked DNA
duplexes with a phosphate residue located on the 5′ side of
the nick (Supplementary Figure S5A); a similar preference
was observed for the PARP2-catalysed DNA-PARylation
activity (Figures 2 and 3). In line with these observa-
tions, recently, Langelier et al. have shown that PARP2-
catalysed auto-PARylation is preferentially activated by 5′-
phosphorylated DNA strand breaks (20). Taken together,
these results suggest that the level of PARPs activation is
important, but efficient PARylation of DNA substrates also
depends on their structures.
We also tested whether DNA oligonucleotides used in
this study can induce PARP1-catalysed protein PARylation
(auto-PARylation). To this end, we incubated unlabelled
ExoA•RexTrec and PARP1 in the presence of NAD+ and
then analysed the PARP1-catalysed protein PARylation by
Western blotting with the anti-PAR and anti-PARP1 anti-
bodies. The results showed that PARP1 is efficiently auto-
PARylated in the presence of a DNA oligonucleotide (Sup-
plementary Figure S5B).
Next, we attempted to evaluate the relative efficiency
of PARP auto-PARylation and DNA PARylation. PARP1
and PARP2 synthesise long branched PAR polymers (with
molecular weight of more than >100 kDa), which in addi-
tion have non-linear bulky structures (49,50). These prop-
erties of PAR polymers impede separation of the HMW
products containing PARylated DNA from that contain-
ing PARylated protein by gel electrophoresis and/or size ex-
clusion chromatography. Therefore, in this study, we used
ExoA•RexTrec/nick-biotin duplex oligonucleotides in which
the RexT strand was 5′-biotinylated in order to separate
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Figure 3. Effects of the type of DNA structures and termini on the PARP1- or PARP2-catalysed formation of PAR–DNA adducts. Fifty nM PARP1 or
PARP2 was incubated with 20 nM [32P]labelled oligonucleotide and 1 mM NAD+ for 30 min at 37◦C. The products of the reaction were separated using
denaturing PAGE and the relative amounts of the PAR–DNA products were measured. (A) Effects of duplex and single-stranded DNA structures on
PARP-catalysed DNA PARylation. (B) Effects of the 3′-terminal ribonucleotide in oligodeoxynucleotides on PARP1- or PARP2-catalysed PARylation of
oligonucleotides. ‘Rib’ in structures 3, 4, 7 and 8 indicates an adenosine ribonucleotide. The data on PARP-catalysed formation of PAR-DNA products
are presented as mean ± SD from three independent experiments.
PARylated DNA from auto-PARylated PARP protein with
the help of streptavidin-coated magnetic particles/beads.
Biotinylated and non-biotinylated ExoA•RexTrec/nick du-
plexes were incubated with PARPs in the presence of ra-
dioactive [adenylate-32P]NAD+; after the reaction, the sam-
ples were fractionated using the beads. The results showed
that incubation of the DNA duplexes with PARPs resulted
in appearance of the [32P]labelled HMW products in the
flow-through fraction, suggesting that both non-radioactive
ExoA•RexTrec/nick and ExoA•RexTrec-biotin duplexes can
activate PARP1 and PARP2 (Supplementary Figure S6).
Fractionation of the [32P]labelled HMW products with
the beads revealed that ∼16% and 19% of the PARP1-
and PARP2-generated [32P]labelled HMW products, re-
spectively, remained bound to the beads after loading and
washing steps. In the control experiments, when we used
non-biotinylatedExoA•RexTrec/nick duplexes, no binding of
[32P]labelled HMWproducts to the magnetic beads was ob-
served, indicating that both PARylated proteins and DNA
do not bind to the beads in a tight manner (Supplementary
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Figure S6). This result suggests that PARP-catalysed auto-
PARylation is∼5–6 timesmore efficient than PARylation of
the biotinylatedDNA substrates. It should be noted that the
ratio of protein PARylation to DNA PARylation might de-
pend on the type of aDNA substrate, NAD+ concentration,
presence of free PAR polymer and biotinylated nucleotides.
Further studies are needed to assess the relative PARylation
of protein andDNAwhen variousDNA structures are used
under varying reaction conditions.
Analysis of the structure and composition of PAR–DNA
adducts
Close examination of the mechanism of the PARP activity
revealed that after addition of the first ADP-ribose unit to
the amino acid acceptor residues on target proteins, PARPs
catalysed PAR chain elongation by transferring additional
ADP-ribose units to the ADP-ribose molecule that was al-
ready attached to the protein through 2′,1′′-O-glycosidic
ribose-ribose bonds (Figure 4A). Thus, every 2′-hydroxyl
group of the ADP-ribose molecule can be used by PARPs
as an acceptor residue. Accordingly, we hypothesised that
DNA strand break termini containing either the 2′ hydroxyl
group of the cordycepin moiety at the 3′ end (which re-
sembles that of the ADP-ribose unit in PAR) or terminal
phosphate residues might both serve as acceptor residues
for ADP-ribose chain initiation by PARPs.
To test this hypothesis, we prepared [32P]labelled PARy-
lated DNA duplexes and then treated them with various
enzymes including (i) PARG that hydrolyses O-glycosidic,
ribose-ribose (1′′→2′) bonds of PAR polymers, producing
monomeric ADP-ribose (Figure 4A); (ii) calf-intestinal al-
kaline phosphatase (CIP) that removes phosphate groups
from the 5′ and 3′ ends of DNA strands; and (iii) snake
venomphosphodiesterase 1 (SVPDE1), which cleavesDNA
in the 3′→5′ direction producing dNMPs and digests py-
rophosphate bonds in a PAR polymer, thereby gener-
ating the 2′-(5′′-phosphoribosyl)-5′-adenosine monophos-
phate (pRib-AMP) compound (Figures 4A and 5D) as
an end product. Treatment of the PARP1-PARylated 5′-
[32P]labelled ExoA•RexTrec duplex with PARG resulted in
complete disappearance of the PAR–DNA adducts and in
restoration of the original 21-mer fragment (Figure 4B, lane
3), indicating that PARGcan efficiently removeADP-ribose
moieties attached toDNA.As expected, PARGalso hydrol-
ysed the HMW PAR–DNA adducts generated by PARP2
(Figure 4B, lane 3 versus 6 and Supplementary Figure S3).
The LMW PAR–DNA adducts (ExoA with two to four
ADP-ribose units attached to DNA) persisted after treat-
ment with PARG (Figure 4B, lane 6). CIP dephosphorylates
free 5′-[32P]labelled ExoA•RexTrec duplex (lanes 4 and 8)
but not the [32P]labelled PAR–DNA adducts generated by
both PARPs (lanes 9 and 10), indicating that the terminal
5′P of the PARylated oligonucleotides is protected. More-
over, efficient shielding of 5′-32P groups in ExoA•RexTrec
duplex from CIP, by the short ADP-ribose oligomers at-
tached to ExoAoligonucleotide (lane 6 versus 7), may imply
that theseDNA5′-phosphates are protected via the covalent
phosphodiester bond between 5′P and C1′ of ADP-ribose.
This unusual C1′-P bond––as compared to the regular
C3′-P phosphodiester bonds in DNA––might be resistant
to the deoxyribonuclease-mediated hydrolysis. Indeed, the
experiment in Supplementary Figure S7A indicated that
the 5′-terminal radioactive phosphorous 32P label on DNA
is protected by a covalently attached PAR polymer also
against ExoI andDNase I (lanes 2, 6 and 8), suggesting that
at least the terminal 5′-32P-dG nucleotide stays attached to
the PAR polymer after these treatments. In order to exam-
ine the sensitivity of the rest of the oligonucleotide duplex
to deoxyribonucleases we constructed the [32P]labelled 5′-
P-ExoA•RexTrec duplex in which the 21-mer ExoA frag-
ment contains cold 5′-end phosphate and a single inter-
nal 32P label. The [32P]labelled ExoA was constructed by
ligating two 5′-phosphorylated cold 8-mer oligonucleotide
and [32P]labelled hot 13-mer oligonucleotide that had been
hybridised to the complementary 40-mer RexT oligonu-
cleotide. As shown in Supplementary Figure S7B, PARP2
and PARP1 ADP-ribosylate the internally [32P]labelled
ExoA•RexTrec duplex and generate [32P]labelled HMW
products (lanes 1 and 5, respectively). As expected, the
DNase I treatment of these products resulted in the dra-
matic loss of HMWproducts (lanes 2 and 6). These data are
suggestive of accessibility of the oligonucleotide duplex in a
PAR-DNA adduct to DNase I treatment and that the inter-
nal 32P residue is not protected by PAR polymer contrary to
5′-terminal 32P residue in HMW products (Supplementary
Figure S7A, lane 8). Taken together, these results strongly
suggest that PARP1 and PARP2 catalyse ADP-ribosylation
(PARylation) of 5′-terminal phosphate residues at DNA
strand break extremities and protect them against the de-
oxyribonucleases tested.
In order to examine whether PARP1 can use the 2′-
hydroxyl group of cordycepin in DNA as an acceptor site,
we used the PARP1-PARylated 3′-32P-cordycepin-labelled
ExoA•RexTrec duplex as the substrate to analyse the prod-
ucts of degradation of the PAR–DNA adducts by SVPDE1
and CIP (Figure 4C). As expected, SVPDE1 effectively de-
graded the free DNA duplex, resulting in a substantial loss
of the 22-mer fragment (lane 3). In contrast, incubation
of the free DNA and PAR–DNA product with CIP alone
had no effect (lanes 2 and 5). Incubation of the PARP1-
treated DNA with SVPDE1 resulted in a dramatic de-
crease in the amount of HMW adducts (lane 6), indicat-
ing that the enzyme cleaves the pyrophosphate bonds in
poly(ADP-ribose) chains. The SVPDE1-catalysed hydrol-
ysis of [32P]labelled PAR–DNA transformed some of the
HMW products back to a free DNA fragment, which mi-
grated as a 22-mer (lane 6) and was apparently more resis-
tant to the 3′ exonuclease degradation than the free ExoA
(lane 3). We presumed that the remaining phosphoribosyl
moiety of PAR at the cordycepin end of labelled ExoA pro-
tects the polymer from SVPDE1 treatment, but may not
significantly change its mobility in the gel. Combined treat-
ment of the 3′-32P-cordycepin-labelled PAR–DNA product
with SVPDE1 andCIP resulted in the appearance of a band
(lane 7) that migrated slightly more slowly than free 22-mer
3′dAM32P-ExoA (lane 1). This result is suggestive of the
presence of a ribose moiety at the 3′ end of the PARylated
ExoA that is left after removal of PAR and phosphate by
SVPDE1 and CIP, respectively.
It should be noted that the presence of 3′P, 3′-
thiophosphate and mismatch residues in the 5′P-
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Figure 4. Analysis of the products of enzymatic digestion of the PAR–DNA adducts. (A) Graphical representation of formation and chemical structure
of poly(ADP-ribose) polymers. (B) Denaturing PAGE analysis of the products of PARG- and CIP-catalysed digestion of the 5′-[32P]labelled PAR–DNA
products. (C) Denaturing PAGE analysis of the products of CIP- and SVPDE1-catalysed digestion of the PARP1-generated 3′-32P-cordycepin-labelled
PAR–DNAproducts. To generate the PAR–DNAproducts, 20 nM 3′dAM32P-ExoA•RexTrec was incubated with 50 nMPARP1 or PARP2 in the presence
of 1 mM NAD+ for 30 min at 37◦C. After that, the samples were heated for 20 min at 80◦C and then incubated with 50 pg/l PARG (in PARP1 buffer),
0.1 U SVPDE1 (in SVPDE1 buffer) or 10 U CIP (in CIP buffer) for 60 min or 30 min at 37◦C. Arrows depict HMW PAR–DNA products and free
oligonucleotides.
ExoA•RexTrec duplex strongly inhibits PARP2-catalysed
DNA PARylation, while the activity of PARP1 is not sig-
nificantly affected by the presence of 3′-end modifications
(Supplementary Figure S8). These results may suggest
that, when acting upon the recessed oligonucleotide duplex
PARP2 DNA-PARylation requires the presence of both
3′OH and 5′P groups in the recessed ExoA strand, whereas
PARP1 is less sensitive to the presence of 3′-end blocking
groups in 5′-phosphorylated ExoA.
Next, we further tested whether PARP1 can utilise 3′P as
the acceptor site for PARylation of duplex DNA, we con-
structed an ExoA•RexTrec duplex containing only 3′- but
not 5′-terminal phosphate residues; in which ExoA oligonu-
cleotide was labelled at the 3′-end with the 32P residue. For
this purpose, we used human Tdp1, which can remove a 3′-
terminal cordycepin nucleoside thus producing an oligonu-
cleotide fragment with a 3′-32P residue (26). Analysis of the
reaction products revealed that, PARP1 catalyses efficient
PARylation of the 3′-[32P]labelled ExoA•RexTrec duplexes
and the resulting [32P]labelled HMW products are resistant
to CIP treatment (Supplementary Figure S9A), implying
that PARylation of DNA protects 3′-terminal phosphates
from the phosphatase. These results suggest that PARP1
can use both 5′- and 3′-terminal phosphate residues as ac-
ceptor sites for DNA-PARylation, and this situation leads
to the formation of a covalent phosphodiester bond be-
tween C1′ of ADP-ribose and either 5′P or 3′P of DNA
strand breaks. Finally, we can conclude that PARP en-
zymes catalyse covalent attachment of an ADP-ribose unit
either to 2′-hydroxyl of a terminal cordycepin via the 1′′→2′
ribose-ribose O-glycosidic bond or via a phosphodiester
bond between DNA terminal phosphates and C1′ of ADP-
ribose.
Characterisation of the PAR-DNAmonomer adducts formed
by enzymatic digestion of the ADP-ribosylated DNA prod-
ucts
To determine with more accuracy the site of link-
age of the ADP-ribose unit to the DNA oligonu-
cleotide, we prepared PARP1- and PARP2-PARylated
DNAusing either [32P]labelled ExoA•RexTrec duplexes and
NAD+ or radioactive [adenylate-32P]NAD+ and unlabelled
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ExoA•RexTrec. We incubated the resulting [32P]labelled
PAR-protein and PAR-DNA adducts with SVPDE1 and
analysed the reaction products using long- and short-
run denaturing PAGE (Figure 5A and B) and thin-layer
chromatography (TLC; Figure 5C). As expected, PARP1
and PARP2 generated [32P]labelled HMW products in the
presence of either [adenylate-32P]NAD+ or [32P]labelled
DNA (Figure 5A, lanes 2 and 3 or 7 and 9). Analysis
of the reaction products by short-run denaturing PAGE
and TLC revealed a major band corresponding to 2′-
(5′′-phosphoribosyl)-5′-adenosine monophosphate (pRib-
AMP; Figure 5B and C, lanes 1 and 5). This monomer
adduct of PAR was identified and characterised previously
(Figure 5D) (51). The SVPDE1-catalysed hydrolysis of
free 3′-[32P]-cordycepin- and 5′-[32P]labelled ExoA•RexTrec
duplexes gave rise to mononucleotides 3′dAM32P and
dGM32P, respectively (Figure 5B and C, lanes 3 and 7),
whose migration was different from that of the pRib-AMP
monomer in the gel and on the TLC plate.
When analysing the products of exonuclease degradation
of 3′-[32P]-cordycepin-labelled PAR–DNA adducts sepa-
rated on the TLC plate, we observed appearance of a band
(Figure 5C, lane 2) that migrated almost exactly as the
pRib-AMP monomer did (lane 1) but was absent in the
SVPDE1-treated free DNA sample (lane 3). In the denatur-
ing gel, the products of SVPDE1-catalysed digestion of the
3′-32P-cordycepin-labelled PAR–DNA migrated as a smear
below the band corresponding to 3′dAM32P (Figure 5B,
lane 2), just as the pRib-AMPmonomer did, which alsomi-
grated as a smear (lane 1). These results show that PARP1
utilises the 2′-hydroxyl group of the 3′dAMP residue at the
3′ end of the 3′-32P-cordycepin-labelled ExoA•RexTrec du-
plex as an acceptor site for ADP-ribosylation. The denatur-
ing PAGE analysis of the products of SVPDE1-treated 5′-
[32P]labelled PAR–DNA did not reveal the appearance of
additional monomer adducts (Figure 5B, lane 6) as com-
pared to the products of degradation of free ExoA (lane
7). This result was expected because PARP2 preferentially
PARylated 5′-[32P]labelled recessed DNA duplexes contain-
ing 3′-hydroxyl at the 3′ end of a gap (Figure 3). There-
fore, the PAR–DNAmono-adduct resulting from SVPDE1
treatment should not contain radioactive 32P. Nonethe-
less, separation of the products generated by PARP2 and
SVPDE1 treatments on the TLC plate revealed the appear-
ance of a new band (not seen in the denaturing gels) that mi-
grated much more slowly than did the dGM32P nucleotide
and faster than the unhydrolysed oligonucleotide (Figure
5C, lane 6). On the basis of this observation and on data
fromCIP-resistance of PARP2-PARylated oligonucleotides
(Figure 4B, lane 7) discussed above, we believe that this new
band corresponds to a phosphoribosyl (pRib) moiety cova-
lently attached via a phosphodiester bond between C1′′ of
ribose and the 5′P residue of the 5′-terminal dGM32P nu-
cleotide in the ExoA oligonucleotide (Figure 5D, 5′P-pRib-
dG).
Identification of the ADP-ribose-DNA adducts by matrix-
assisted laser desorption ionization time-of-flight (MALDI-
TOF) mass spectrometry (MS)
In the above studies, a putative molecular mechanism of
PARP-catalysed DNA PARylation was deduced from the
migration pattern of end-labelled DNA fragments in a de-
naturing polyacrylamide gel and TLC plates (Figure 5).
To further substantiate the mechanism of action of PARP
enzymes on duplex oligonucleotides, we characterised the
nature of the PAR-DNA adducts by MALDI-TOF MS
analysis of the PARylated DNA products. For this pur-
pose, the reaction products, generated during incubation
of the unlabelled ExoA•RexTrec recessed duplex oligonu-
cleotide with PARP1, were subjected to MS analysis. The
analysis of the MALDI-TOF mass spectrum of the reac-
tion products did not reveal signals (peaks) with the molec-
ular mass corresponding to the PARylated oligonucleotides
(Supplementary Figure S10). Nevertheless, the mass spec-
trum showed multiple peaks including two mono-charged
product peaks corresponding to free 21-mer ExoA and
40-mer RexT oligonucleotides and multiple peaks rang-
ing from 3263.1 to 8674.5 Da and 2826.1 to 4888.0 Da
which correspond to short poly(ADP-ribose) oligomers
with masses consistent with the multiple addition of 540
Da (the mass of the ADP-ribose moiety minus the mass
of a water molecule) to a single ADP-ribose and to a
NAD+ molecule, respectively (Supplementary Figure S10).
These results suggest that the amount of intermediary
LMWPAR-DNA products generated during incubation of
PARP1 with DNA was insufficient for detection by our in-
strument. It should be noted that the sensitivity ofMALDI-
TOF measurements decreases with the increasing oligonu-
cleotide size, and oligonucleotides 40 nt long ‘fly’ poorly
(Supplementary Figure S10). According to these results,
we can say that the HMW products with the polymer
chain up to 200–300 ADP-ribose units (>100 kDa) can-
not be detected by MALDI-TOF because of an extremely
weak signal. It should be noted that PARP2-catalysed
PARylation of the regular short duplex oligonucleotides is
more efficient as compared to that of PARP1, thus pro-
viding an opportunity to isolate PARP2-generated LMW
adducts after limited PARG treatment. Hence, we decided
to convert the PARP2-generated HMW products to mono-
ADP-ribosylated oligonucleotides by the PARG treatment
and to purify these mono-adducted DNAs by denatur-
ing PAGE. To this end, an unlabelled, cold ExoA•RexTrec
duplex oligonucleotide was 5′-phosphorylated by PNK in
the presence of cold ATP, in order to obtain phosphory-
lated 5′ ends, which are required for the efficient PARyla-
tion of DNA termini, and was then incubated with PARP2
in the presence of NAD+. The resulting HMW products
were treated with PARG, and the products were sepa-
rated by denaturing PAGE. As shown in Figure 4B, mild
PARG treatment of [32P]labelled PARylated DNA pro-
duced free ExoA and multiple bands migrating just above
the 21-mer fragment that corresponds to LMWPAR-DNA
adducts containing among others mono- and di-(ADP-
ribosylated) oligonucleotides. Bands corresponding to the
non-radioactivemono-ADP-ribosylated 5′-phosphorylated
ExoA were purified from the gel, mixed with the cold 5′-
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Figure 5. Separation and characterisation of PAR–DNAmono-adducts by denaturing PAGE and TLC. (A) The long-run denaturing PAGE analysis of the
products of SVPDE1-catalysed digestion of the 3′-32P-cordycepin- and 5′-[32P]labelled PAR–DNA adducts, free DNA and the PAR polymer. The samples
were desalted before loading on the gel. (B) As in panel A but short-run denaturing PAGE. The samples were not desalted before loading on the gel. (C)
TLC separation of the products of SVPDE1-catalysed digestion of the 3′-32P-cordycepin- and 5′-[32P]labelled PAR–DNA adducts, free DNA and the PAR
polymer. The samples were not desalted before loading on the plate. (D) Graphical representation of chemical structures of the phosphoribosyl adenosine
monophosphate adducts. The pRib-AMP adduct is generated by digestion of the [32P]labelled PAR by SVPDE1, whereas the 2′-pRib-3′dAMP and 5′P-
pRib-dGadducts are generated by digestion of the 3′-32P-cordycepin-labelled and 5′-[32P]labelled PAR–DNAby SVPDE1, respectively. Arrow ‘X’ indicates
the putative 2′-pRib-3′dAMP adduct, ‘Y’ points to traces of a putative 3′-terminal dAMP-3′dAMP dinucleotide, ‘Z’ indicates the putative 5′P-pRib-dG
adduct containing a pRib moiety covalently attached to 5′P of dGMP, ‘AM32P’ means adenosine 5′-[32P]monophosphate, ‘pRib-AM32P’ stands for pRib-
AMP with adenosine 5′-[32P]monophosphate, ‘32P-NAD+’ means [adenylate-32P]NAD+, ‘3′dAM32P’ is cordycepin 5′-[32P]monophosphate, ‘dGM32P’
denotes 2′-deoxyguanosine 5′-[32P]monophosphate, and 32P means free phosphate.
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phosphorylated ExoA•RexTrec duplex to obtain internal
atomic mass markers, and were subjected to MALDI-TOF
MS analysis. MALDI-TOF analysis of the mock-treated
ExoA•RexTrec duplex showed the presence of two peaks at
[M-H]¯ = 6637.9 and 6557.5 Da corresponding to the phos-
phorylated and unphosphorylated ExoA oligonucleotide,
respectively, as well as two small peaks corresponding to
RexT and 5P-RexT oligonucleotides (Figure 6A). As shown
in Figure 6B, analysis of the mass spectra of the mono-
ADP-ribosylated ExoA•RexTrec duplex revealed a mono-
charged peak at [M-H]¯ = 7180.5 Da corresponding to the
5′-phosphorylated 21-mer ExoA that contains one ADP-
ribose residue (calculated mass, 7180.2 Da) and other peaks
corresponding to the 5′-phosphorylated and unphosphory-
lated free ExoA and RexT oligonucleotides. Taken together,
these results indicate that PARP2 catalyses covalent attach-
ment ofADP-ribose residues to a 21-mer 5′-phosphorylated
ExoA oligonucleotide. In conclusion, these data are in good
agreement with those obtained by the denaturing PAGE
and TLC (Figures 4 and 5) and unambiguously confirm the
formation of the covalent PAR-DNA adducts.
Formation of the phosphoribosylated DNA adducts by cleav-
age of PAR–DNA with a nucleoside diphosphate-linked moi-
ety X (Nudix) hydrolase
The SVPDE1-catalysed hydrolysis of phosphodiester bonds
in DNA and PAR polymers is a commonly used method
for research into the structure of DNA adducts and ADP-
ribose units (51). However, a drawback of SVPDE1 is
its strong exonucleolytic activity on DNA; this activity
may pose a problem during characterisation of PAR–DNA
products (Figure 4). Recently, it was demonstrated that nu-
cleoside diphosphate-linked moiety X (Nudix) hydrolases
can act on a free ADP-ribose residue (and on a PAR poly-
mer attached to a protein) by hydrolysing the pyrophos-
phate bonds (52,53). Nudix hydrolases can trim a long
PAR polymer attached to DNA, and this effect could be
used to characterise ADP-ribosylation sites on DNA. To
further corroborate the mechanism of action of PARP1
and PARP2 enzymes on duplex oligonucleotides, we exam-
ined migration patterns of 5′- and 3′-end-labelled PARy-
lated DNA fragments by denaturing PAGE after treatment
with human Nudix hydrolase, NUDT16. For this purpose,
the 3′dAM32P-labelled and 3′-[32P]labelled ExoA•RexTnick
duplexes were incubated in the presence of PARP1 and
NAD+, whereas the 5′-[32P]labelled ExoA•RexTnick duplex
was incubated with PARP2 and NAD+ at 37◦C for 30 min
to obtain PAR-DNA substrates for NUDT16. After DNA
PARylation, the resulting [32P]labelledHMWproducts were
further incubated with PARG, CIP, and an excess amount
of NUDT16, and then analysed by denaturing PAGE.
As shown in Figure 7, PARP1 and PARP2 gener-
ated [32P]labelled HMW products, which did not enter
the gel (panel A, lane 4 and panel B, lane 5, respec-
tively). As expected, CIP removed the 3′P residue in the
free ExoA•RexTnick duplex (Figure 7A, lane 10), whereas
PARP1-generated [32P]labelled HMW products were resis-
tant to CIP (lanes 5 and 12). Incubation of the [32P]labelled
free ExoA•RexTrec/nick duplexes with an excess amount of
NUDT16 resulted in strong oligonucleotide degradation
(Figure 7A, lanes 3 and 10, Figure 7B, lane 3 and Supple-
mentary Figure S9B), suggesting that human NUDT16 hy-
drolase may have a weak nucleolytic activity. Incubation of
the PARP1-generated [32P]labelled HMWproducts with an
excess amount of NUDT16 resulted in complete degrada-
tion of the PAR–DNA adducts, and in the appearance of a
distinct DNA fragment (Figure 7A, lane 6 and Supplemen-
tary Figure S9B) that migrated somewhat more slowly than
did the free 22-mer and 21-mer ExoA fragments (lanes 1 and
9). These results are suggestive of the presence of a phos-
phoribosyl (pRib) moiety attached to DNA termini (22*-
Rib-p and 21-*p-Rib-p, where the asterisk denotes a ra-
dioactive label), remained after hydrolysis of pyrophosphate
bonds in the PAR polymer by NUDT16. In agreement with
these observations, incubation of the [32P]labelled HMW
products in the presence of both CIP and varying concen-
trations of NUDT16 resulted in the appearance of 22-mer
and 21-mer 3′-monoribosylated products (Figure 7A, lanes
7 and 16, respectively), which migrated more slowly than
did the native DNA substrates (lanes 1 and 9, respectively)
and the 3′-mono-phosphoribosylated products (Figure 7A,
lanes 6 and Supplementary Figure S9B, respectively). This
finding is indicative of CIP-catalysed dephosphorylation of
the 22*-Rib-p and 21-*p-Rib-p fragments.
When incubating PARP1-generated 3′-[32P]labelled
HMW products with CIP and limited concentrations of
NUDT16 (2–10 M), we observed formation of two slowly
migrating bands (Figure 7A, lanes 13–15). We can state
that the upper band corresponds to the ribosylated 21-mer
fragment, which in addition to ribose contains an ADP-
ribose moiety, referred to as 21-*p-Rib-ADP-Rib here. It
should be stressed that CIP does not remove the 3′-32P
residue in PARylated ExoA, even after removal of the PAR
polymer by NUDT16 (lanes 13–16), indicating that the Rib
moiety protects 3′P in the 3′-[32P]ExoA-p*-Rib adduct,
and that PARP1 can also catalyse covalent attachment of
an ADP-ribose unit to ExoA via a phosphodiester bond
between DNA 3′P and C1′ of ADP-ribose.
As shown in Figure 7B, incubation of the PARP2-
generated 5′-[32P]labelled HMW products with PARG
caused extensive degradation of PAR–DNA products and
appearance of the intermediately migrating LMW PAR-
DNA products (lane 6). In contrast, incubation of the 5′-
[32P]labelled HMW products with an excess amount of
NUDT16 resulted in complete degradation of the HMW
and LMW PAR-DNA adducts and in the appearance of a
distinct DNA fragment (lane 7), which migrated marginally
more slowly than did the free 21-mer ExoA fragment (lane
4). Incubation of the reaction mixture with CIP resulted
in appearance of a 21-mer Rib-*p-ExoA product (lane 8),
which migrated more slowly than did the free 21-mer ExoA
(lane 4) and p-Rib-*p-ExoA fragments (lane 7). This result
was suggestive of dephosphorylation of the p-Rib-*pExoA
fragment by CIP. Again, we observed protection of the
5′-32P residue in PARylated ExoA from CIP by a mono-
phosphoribose moiety remaining after NUDT16-catalysed
hydrolysis, suggesting that PARP2 catalysed covalent at-
tachment of an ADP-ribose unit to ExoA via a phosphodi-
ester bond betweenDNA5′P andC1′ ofADP-ribose. Taken
together, these results are in complete agreement with the
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Figure 6. MALDI-TOF MS analysis of the mono-ADP-ribosylated oligonucleotide product resulting from incubation of the nicked 5′-phosphorylated
oligonucleotide duplex with PARP2 and PARG. The 5′-phosphorylated ExoA•RexTnick duplex was PARylated by means of PARP2 and then treated with
PARG. Bands corresponding to the mono-ADP-ribosylated 5′-phosphorylated ExoA product were purified by denaturing PAGE and mixed with cold
5′-phosphorylated ExoA•RexTrec duplex for further analysis. (A) A MALDI-TOF spectrum of the control mock-treated phosphorylated ExoA•RexTrec
duplex; (B) MALDI-TOF spectrum of the unpurified PARP2 reaction products with addition of the purified 21-mer ExoA-mono-ADP-ribose fragment.
For details see Materials and Methods.
above-mentioned MALDI-TOF MS data and confirm the
formation of the covalent PAR–DNA complexes/adducts.
DISCUSSION
There are several examples of post-replicative alterations of
DNA in higher eukaryotes such as cytosine methylation,
deamination, oxidation (54), adenine methylation (55) and
mono(ADP-ribosyl)ation of guanine residues in DNA by
pierisin 1 from cabbage butterfly (56). In the present study,
using in vitro approaches, we demonstrated that PARP1
can ADP-ribosylate DNA strand break termini contain-
ing terminal phosphates and a 2′-OH group in ss and ds-
DNA, respectively, whereas PARP2 preferentially acts on
5′-terminal phosphates at DSB termini in nicked duplex
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Figure 7. Analysis of the products of NUDT16-catalysed hydrolysis of PAR-DNA adducts generated by PARP1 and PARP2. The 10 nM 3′dAM32P-
labelled and 3′-[32P]labelled ExoA•RexTrec duplexes were incubatedwith 100 nMPARP1 and 1mMNAD+, and the 40 nM5′-[32P]labelled ExoA•RexTnick
duplex was incubated with 100 nM PARP2 and 1 mM NAD+ at 37◦C for 30 min. After incubation with PARPs, the samples were heated for 20 min at
80◦C and the resulting [32P]labelled HMW products were further incubated with 50 pg/l PARG, 1 U SVPDE1, 10 U CIP or 2–20 M NUDIX16. (A)
Denaturing PAGE analysis of the products of NUDT16 and CIP catalysed hydrolysis of the PARP1-generated 3′-[32P]labelled PAR-DNA adducts. To
generate a DNA duplex containing a 3′-terminal 32P residue, the 3′dAM32P-labelled ExoA•RexTrec duplex was treated with Tdp1. Lanes 1–8, 3′dAM32P-
labelled ExoA•RexTrec duplex; lanes 9–17, 3′-[32P]labelled ExoA•RexTrec duplex. (B) Denaturing PAGE analysis of the products of PARG-, SVPDE1-,
CIP- and NUDT16-catalysed hydrolysis of the PARP2-generated 5′-[32P]labelled PAR-DNA adducts (lanes 1–9). Arrows indicate phosphoribosylated
(Rib-p), ribosylated (Rib) and native [32P]labelled 21-mer and 22-mer oligonucleotides, ‘*p’ stands for a labelled phosphate residue. For more details, see
Materials and Methods.
DNA. We did not find evidence for the ADP-ribosylation
of 3′-OH groups at the termini of a DNA strand break.
It should be stressed that we used duplex DNA oligonu-
cleotides with a nicked, gapped, and recessed strand and
oligonucleotides in single-stranded form as the substrates
for PARP-catalysed PARylation. These DNA duplexes can
be generated either by direct action of reactive oxygen
species or during DNA replication, or by different DNA
excision repair pathways when they act on DNA damage.
For example, the nicked and gapped DNA duplexes mimic
an intermediate product of the BER, NER and other DNA
excision repair pathways. DNA strand-break termini con-
taining 3′-phosphate and 3′-blocking groups can represent
the products of action of bi-functional DNA glycosylases
and Tdp1-like enzymes. The recessed DNA duplexes can
be generated by replication fork collapse and/or by 3′→5′
resection of DNA strand breaks. All DNA duplexes that
were used as substrates in this work contained at least
one DSB terminus, suggesting that PARP-catalysed DNA-
PARylation may specifically occur at sites of DSB in chro-
mosomes.
The phenomenon of covalent trapping of PARP1 and
PARP2 by an AP site-containing DNA resulting in forma-
tion of cytotoxic trapped PARP-DNA complexes has been
described in several studies (57–59). In the present study,
however, we did not observe formation of the covalent
DNA–protein cross-link between PARPs and [32P]labelled
oligonucleotides, but rather the formation of the covalent
PAR-DNA adducts. It should be emphasized that in this
work we used no DNA substrates containing a natural AP
site, instead we used DNA containing a synthetic AP site
and regular DNA bases which cannot form covalent DNA–
protein crosslinks.
Recently, the 3D structure of full-length PARP1 bound
to dumbbell DNA with a SSB was assembled using com-
bined NMR/X-ray crystallography and mass spectrome-
try approaches (17,18). The structures revealed that PARP1
recognises and bends a DNA duplex at the site of the strand
break through cooperative action of two N-terminal zinc
fingers (Zn1 and Zn2) and then drives stepwise assembly
of the remaining Zn3 and WGR domains leading to un-
folding of the autoinhibitory helical subdomain of the CAT
and PARP1 activation. Nevertheless, the specificity for ac-
ceptor sites and the substrate selection for PARylation ac-
tivity remain open questions. We can hypothesize that the
substrate specificity depends mainly on the recruitment of
protein or DNA acceptor sites to the proximity to the
catalytic domain. Structural modelling performed in these
studies showed that the BRCT-WGR linker remains flexi-
ble and can reach the active site of PARP1, thus providing
an explanation for the auto-modification (in cis mode) of
this protein region. In the 3D structures of PARP1/DNA
complexes, it is self-evident that the DNA-binding site of
PARP1 in its active conformation is too far from its ac-
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tive site in the CAT domain, suggesting that the DNA ter-
mini already bound to PARP1 cannot serve as acceptor sites
for DNA-PARylation by the same PARP1 molecule. How-
ever, the second breakage site in the same DNA molecule
might interact with the CAT domain. Similarly, it was sug-
gested that two molecules of PARP1 can ADP-ribosylate
each other in trans mode when two DNA binding sites of
the same DNAmolecule are closely adjacent, e.g. in a short
duplex DNA containing two DSB ends (17). In our work,
all oligonucleotide substrates have at least two DNA break-
age sites; therefore, binding of PARPs to one DNA break-
age site will activate the CAT domain which in turn could
target and ADP-ribosylate in transmode an acceptor group
at the second breakage site of the same DNA molecule.
Accordingly, acceptor sites at DNA strand breaks already
bound to DNA binding domains of a PARP are expected
to be less accessible for DNA-PARylation by the CAT do-
main of the same PARPmolecule. It was shown that in con-
trast to PARP1, which has rather high affinity for DNA
with a blunt-end DSB, PARP2 binds to a DSB with low
affinity (22,48,60). Indeed, PARP2 more efficiently PARy-
lated the 21-mer fragment containing a 5′-terminal phos-
phate at the DSB in the nicked and 3′-recessed duplexes, as
compared to PARP1 (Figures 2 and 3), despite the stronger
overall PARP1 activation on these DNA substrates (Sup-
plementary Figure S5A). This phenomenon might be due
to differences in affinity of PARPs for the blunt DSB in du-
plex DNA, rather than the differences in the overall level
of PARylation activity. On the other hand, greater ADP-
ribosylation of 5′-terminal phosphate at the DSB end of the
nicked (as compared to recessed) duplex by PARP2 (Fig-
ure 2), which is shown to be activated by 5′ phosphory-
lated nicks ((20) and Supplementary Figure S5A), support
the notion that a PARP’s activation is important for effi-
cient DNA-PARylation. Nevertheless, DNA-binding and
DNA acceptor sites during PARP-catalysed DNA–ADP-
ribosylation might be different. This notion is also in line
with the observed inhibition of PARP2-catalysed ADP-
ribosylation of the 5′-terminal phosphate of 21-mer ExoA
in the 5′P-ExoA•RexTrec duplex when the same ExoA con-
tains modifications at the 3′-end (Supplementary Figures
S8). In conclusion, our results suggest that both the ac-
tivation of PARPs and the accessibility of the DNA ac-
ceptor groups (terminal phosphates or 2′OH of cordycepin
residues) for the activated CAT domain of DNA-bound
PARPs are necessary for efficient DNA-PARylation. Fur-
ther research in needed to determine in detail the structural
basis and molecular mechanisms underlying PARylation of
DNA ends by PARP enzymes.
Detection and efficient repair of DNA damage in a eu-
karyotic cell are challenging tasks because of the pres-
ence of tightly packed chromatin structures that limit ac-
cess of the DNA repair machinery to the damaged sites.
The PARP-catalysed covalent post-translational modifica-
tion of nuclear proteins including histones represents an
efficient chromatin remodelling mechanism that enables
DNA repair and transcription in condensed genome ar-
eas. Electronmicroscopic visualization and atomic forcemi-
croscopy of the PAR polymer synthesised by PARP1 and
PARP2, revealed a dense tree-like structure where the num-
ber of branches increased with the size of the PAR poly-
mer, which still remains bound to single- and double-strand
DNA breaks (49,61). The branching points occur in a very
regular manner, with approximately 40 linear ADP-ribose
residues between two branching (2′′–1′′′) ribose–ribose link-
ages, thus reflecting the distance that allows for initiation of
a new synthesis origin (62). According to these observations
and our data, we can hypothesize that PARPs are capable
of circular rotation around the DNA molecule while syn-
thesising a PAR polymer, and this situation can introduce
supercoils into DNA and result in a change of the duplex
helicity. This mechanism may explain the phenomenon of
chromatin decondensation without a release of PARylated
histones from DNA (63).
The finding that termini of a DNA strand break can
be modified by covalent attachment of poly(ADP-ribose)
chains in vitro suggests that in vivo cellular DNA may un-
dergo post-replicative modification in response to DNA
damage. Therefore, we cannot rule out that the observed bi-
ological effects of PARP-catalysed modification of cellular
macromolecules could be, at least partially, due to simulta-
neous PARylation of proteins and DNA. Furthermore, the
observed PARylation of DNA strand breaks may also have
an impact on overall PARP-catalysed PARylation activity.
Here, we can say that in vivo, the PARP-catalysed modifica-
tion of DNA termini in a broken duplex molecule (i) pro-
vides a stable benchmark of the location of a DNA strand
break on a chromatin map; (ii) not only recruits repair pro-
teins but also increases the mobility of damaged chromo-
somal loci from silenced to active chromatin (to accelerate
DNA repair and to control transcription); (iii) blocks repli-
cation fork progression through interference with replica-
tive DNA helicases and inhibits the toxic non-homologous
end-joining via inhibition of the binding of Ku protein to
double-strandDNA ends. It should be noted that according
to our findings in the absence of PARG, the DNAmodifica-
tions produced by PARPs would be highly toxic; indeed, a
gene knockout of PARG causes early embryonic mortality
(39). Furthermore, PARG can be recruited toDNAdamage
sites through interaction with PCNA; the latter is recruited
and loaded onto gapped or recessed DNA duplexes (64).
At present, we do not have direct evidence for the pres-
ence of PARylated DNA adducts in vivo. However, an ef-
ficient in vitro PARylation of DNA strand break extremi-
ties by the purified PARP proteins (described in this work),
strongly suggests that this type of post-replicative modifica-
tion ofDNAcan also occur in living cells.Moreover, numer-
ous observations showing formation of the PAR polymers
in cells subjected to DNA damage do not allow us to dis-
tinguish between PARylated proteins and PARylated DNA
products.
The phenomenon of ADP-ribosylation of a terminal
phosphate group was observed in vivo and in vitro for the
phosphate group of phosphoserine in histones from rat
liver; these findings further support the notion that phos-
phate residues could serve as acceptor sites for generation of
ADP-ribose-phosphate adducts, but the enzymes responsi-
ble for their formation are still unknown (65,66). Our data
suggest that PARP1 and PARP2 enzymes could be involved
in ADP-ribosylation of the phosphate groups present in
proteins and DNA strand breaks in vivo and in vitro.
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